Sugi Predict

Sugi Predict / Compounds / SCHEMBL289536

SCHEMBL289536

SCHEMBL289536

O=C(O)c1cc(O)c(Br)c(O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.64
▸ CA1 P00915 3/20 0.64
▸ CA2 P00918 3/20 0.64
▸ CA7 P43166 3/20 0.64
▸ CA9 Q16790 3/20 0.64
▸ CA14 Q9ULX7 3/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ MAPT P10636 2/20 0.64
▸ CA4 P22748 2/20 0.64
▸ CA6 P23280 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ LMNA P02545 1/20 0.64
▸ TP53 P04637 1/20 0.64
▸ CA3 P07451 1/20 0.64
▸ SELL P14151 1/20 0.64
▸ HPGD P15428 1/20 0.64
▸ SELP P16109 1/20 0.64
▸ FUT4 P22083 1/20 0.64
▸ DPP4 P27487 1/20 0.64
▸ MAPK1 P28482 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21821500 0.86 CA1 (0.54) CA12CA1CA2CA7CA9
SCHEMBL25977593 0.84 TTR (0.59) CA12CA1CA2CA7CA9
SCHEMBL26121716 0.84 KDM4E (0.58) CA12CA1CA2CA7CA9
SCHEMBL16049891 0.84 TPMT (0.56) CA12CA1CA2CA7CA9
SCHEMBL25981011 0.84 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL3461631 0.78 TTR (0.78) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL15012 0.78 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL1845406 0.78 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL30375631 0.78 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL678990 0.78 CA12 (1.00) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055051-A1 Compound with anti-tumor activity, preparation method therefor, and use thereof OCEAN UNIV CHINA (CN) 2026-02-26 — — US claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 — — EP claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 — — WO claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 — — CN claimed
CN-117861626-A Preparation method of cyclodextrin chromatographic stationary phase 中国药科大学 2024-04-12 — — CN claimed
WO-2024031970-A1 COMPOUND WITH ANTI-TUMOR ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国海洋大学 2024-02-15 — — WO claimed
CN-113816940-A Nicotine salts, co-crystals and salt co-crystal complexes R.J.雷诺兹烟草公司 2021-12-21 — — CN claimed
CN-113754634-A Nicotine salts, co-crystals and salt co-crystal complexes R.J.雷诺兹烟草公司 2021-12-07 — — CN claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 — — US claimed
US-9587147-B2 Pressure-sensitive adhesive compositions, polarizers and liquid crystal displays comprising the same LG CHEM, LTD. (KR) 2017-03-07 — — US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 — — US claimed
EP-2230287-B1 PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME LG CHEMICAL LTD (KR) 2013-06-12 — — EP claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 — — US claimed
US-20110032455-A1 PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME LG CHEM, LTD. (KR) 2011-02-10 — — US claimed
WO-2010118241-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2010-10-14 — — WO claimed
EP-2230287-A2 PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME LG Chem, Ltd. (KR) 2010-09-22 — — EP claimed
CN-1174286-C Photosensitive material containing diazo compound ������������ʽ���� 2004-11-03 — — CN claimed
US-6190823-B1 4-(DIALKYLAMINO)-3-CHLOROBENZENEDIAZONIUM COMPOUND SOMAR CORPORATION (JP) 2001-02-20 — — US claimed
EP-0691323-A1 Process for preparing 3,5-dihydroxy 4-bromobenzoic acid BAYER AG (DE) 1996-01-10 — — EP claimed
US-4401744-A Diazotype compositions with improved printing performance ANDREWS PAPER & CHEMICAL CO., INC. (US) 1983-08-30 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS CA12 4479/4885CA1 4047/4885CA2 3509/4885
US-20260055051-A1 Compound with anti-tumor activity, preparation method therefor, and use thereof RCC2, WEE2, MET CA12 374/4885CA1 549/4885CA2 754/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS CA12 4479/4885CA1 4047/4885CA2 3509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.